Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To revise the boundaries of the Gettysburg National Military Park to include the Gettysburg Train Station and certain land along Plum Run in Cumberland Township, to limit the means by which property within such revised boundaries may be acquired, and for other purposes.
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Rebates for Medicare Part D; animal health; Federal preemption for prescription drugs; drug importation; and drug shortages. H.R. 1513; S. 810
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NUCLEAR ENERGY INSTITUTE via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · 1@
Nuclear Regulatory Commission
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES ENRICHMENT CORPORATION (USEC) via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · 1T
Source: Senate LDA
| CELLULAR BIOENGINEERING INC |
| 21 |
| 2006–2012 |
| TURNER ENTERPRISES, INC. | 21 | 2009–2014 |
| PFIZER | 19 | 2009–2013 |
| ENVIROSOURCE TECHNOLOGIES | 18 | 2002–2010 |
| FIRST ENERGY | 15 | 2002–2009 |
| VISA | 15 | 2010–2013 |
| NUCLEAR ENERGY INSTITUTE | 14 | 2002–2014 |
| TE CONNECTIVITY, INC. | 14 | 2011–2013 |
| COCA-COLA COMPANY | 13 | 2011–2014 |
| AIG ENVIRONMENTAL | 12 | 2002–2007 |
| OWENS-ILLINOIS INC | 11 | 2011–2013 |
| WINE AND SPIRITS WHOLESALERS OF AMERICA | 11 | 2011–2013 |
| PUBLIC SERVICE COMPANY OF NEW HAMPSHIRE | 7 | 2011–2013 |
| AMERICAN CHEMISTRY COUNCIL | 5 | 2010–2011 |
| EDISON ELECTRIC INSTITUTE | 5 | 2002–2005 |
| GENERAL ELECTRIC COMPANY (PREVIOUSLY REPORTED AS GE AVIATION) | 5 | 2011 |
| NORTHEAST UTILITIES | 5 | 2012–2013 |
| SUNOCO INC | 3 | 2006–2007 |
| TERGEO OCEANS SYSTEM CORP | 3 | 2005–2006 |
| AK STEEL | 1 | 2013 |
| E-LYNXX CORP | 1 | 2006 |
| STANLEY BLACK & DECKER INC | 1 | 2002 |
| SUNCOR | 1 | 2002 |
| TYCO ELECTRONICS | 1 | 2011 |
Drug safety and drug counterfeiting; Rebates for Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages; track and trace; H.R. 3204; S. 959.
Drug safety and drug counterfeiting; Rebates for Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages; track and trace; H.R. 3204; S. 959.
Jacob Sexton Military Suicide Prevention Act of 2013
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Rebates for Medicare Part D; animal health; Federal preemption for prescription drugs; drug importation; and drug shortages. H.R. 1513; S. 810
Pharmaceutical Quality, Security, and Accountability Act
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Rebates for Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages; track and trace; H.R. 3204; S. 959.
Pharmaceutical Quality, Security, and Accountability Act
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Rebates for Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages; track and trace; H.R. 3204; S. 959.
American Taxpayer Relief Act of 2012
Client: NEXTERA ENERGY INC · Firm: WILLIAMS AND JENSEN, PLLC
Energy Bill, Section 45 wind energy tax credit extension, dividend rates, H.R. 8.
Great Ape Protection and Cost Savings Act of 2011
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Rebates for Medicare Part D; animal health; Federal preemption for prescription drugs; drug importation; and drug shortages. H.R. 1513; S. 810
Clean Energy Empowerment Zone Act of 2011
Client: WINE AND SPIRITS WHOLESALERS OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Support state-based alcohol regulation systems, H.R. 1611, The Care Act.
H.R. 3156, Consumer Debit Card Protection Act; credit card practices; interchange fees; prepaid card fee; and financial literacy issues.
American Taxpayer Relief Act of 2012
Client: NEXTERA ENERGY INC · Firm: WILLIAMS AND JENSEN, PLLC
Energy Bill, Section 45 wind energy tax credit extension, dividend rates, H.R. 8.
Clean Energy Empowerment Zone Act of 2011
Client: WINE AND SPIRITS WHOLESALERS OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Support state-based alcohol regulation systems, H.R. 1611, The Care Act.
Clean Energy Empowerment Zone Act of 2011
Client: WINE AND SPIRITS WHOLESALERS OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Support state-based alcohol regulation systems, H.R. 1611, The Care Act.
Clean Energy Empowerment Zone Act of 2011
Client: WINE AND SPIRITS WHOLESALERS OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Support state-based alcohol regulation systems, H.R. 1611, The Care Act.
H.R. 3156, Consumer Debit Card Protection Act; credit card practices; interchange fees; prepaid card fee; and financial literacy issues.
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Prescription drug advertising; animal health; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
America's Affordable Health Choices Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Prescription drug advertising; animal health; and Federal preemption for prescription drugs.
Patient-Centered Outcomes Research Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Prescription drug advertising; animal health; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
American Clean Energy Leadership Act of 2009
Client: TURNER ENTERPRISES, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Solar and wind energy, and "cap and trade" legislation, including H.R. 2454 and S. 1462.
American Clean Energy Leadership Act of 2009
Client: TURNER ENTERPRISES, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Solar and wind energy, and "cap and trade" legislation, including H.R. 2454 and S. 1462.
American Clean Energy Leadership Act of 2009
Client: TURNER ENTERPRISES, INC. · Firm: WILLIAMS AND JENSEN, PLLC
solar and wind energy, and "cap and trade" legislation including H.R. 2454 and S. 1462
American Clean Energy Leadership Act of 2009
Client: TURNER ENTERPRISES, INC. · Firm: WILLIAMS AND JENSEN, PLLC
solar and wind energy, and "cap and trade" legislation including H.R. 2454 and S. 1462
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Polluter Pays Restoration Act
Client: AMERICAN CHEMISTRY COUNCIL · Firm: WILLIAMS AND JENSEN, PLLC
legislation pertaining to tax, superfund tax, s. 3164
Polluter Pays Restoration Act
Client: AMERICAN CHEMISTRY COUNCIL · Firm: WILLIAMS AND JENSEN, PLLC
legislation pertaining to tax, superfund tax, s. 3164
Polluter Pays Restoration Act
Client: AMERICAN CHEMISTRY COUNCIL · Firm: WILLIAMS AND JENSEN, PLLC
legislation pertaining to tax, superfund tax, s. 3164
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Prescription drug advertising; animal health; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
To include B20 biodiesel blends as an alternative fuel for corporate average fuel economy purposes.
Client: TURNER ENTERPRISES, INC. · Firm: WILLIAMS AND JENSEN, PLLC
solar and wind energy, and "cap and trade" legislation including H.R. 2454 and S. 1462
To include B20 biodiesel blends as an alternative fuel for corporate average fuel economy purposes.
Client: TURNER ENTERPRISES, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Solar and wind energy, and "cap and trade" legislation, including H.R. 2454 and S. 1462.
To include B20 biodiesel blends as an alternative fuel for corporate average fuel economy purposes.
Client: TURNER ENTERPRISES, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Solar and wind energy, and "cap and trade" legislation, including H.R. 2454 and S. 1462.
To include B20 biodiesel blends as an alternative fuel for corporate average fuel economy purposes.
Client: TURNER ENTERPRISES, INC. · Firm: WILLIAMS AND JENSEN, PLLC
solar and wind energy, and "cap and trade" legislation including H.R. 2454 and S. 1462
American Middle Class Tax (AMT) Relief Act of 2007
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Keep Our Promise to America's Children and Teachers Act
Client: VISA · Firm: WILLIAMS AND JENSEN, PLLC
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
Keep Our Promise to America's Children and Teachers Act
Client: VISA · Firm: WILLIAMS AND JENSEN, PLLC
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
Keep Our Promise to America's Children and Teachers Act
Client: VISA · Firm: WILLIAMS AND JENSEN, PLLC
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; and America's Healthy Future Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including the Affordable Health Choices Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including the Affordable Health Choices Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; and America's Healthy Future Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; and America's Healthy Future Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including the Affordable Health Choices Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
America's Affordable Health Choices Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; and America's Healthy Future Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
America's Affordable Health Choices Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Patient-Centered Outcomes Research Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Patient-Centered Outcomes Research Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; and America's Healthy Future Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Patient-Centered Outcomes Research Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including the Affordable Health Choices Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including the Affordable Health Choices Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; and America's Healthy Future Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; and America's Healthy Future Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including the Affordable Health Choices Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; and America's Healthy Future Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including the Affordable Health Choices Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; and America's Healthy Future Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including the Affordable Health Choices Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
American Middle Class Tax (AMT) Relief Act of 2007
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; Affordable Health Choices Act; America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Funding Issues; Energy Bill; and Energy and Water Appropriations.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, White House Office
PINNACLE WEST CAPITAL CORPORATION via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · 1T
NRC Oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
TURNER ENTERPRISES, INC. via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · 1T
Legislation affecting solar and wind energy
Legislation affecting solar and wind energy
Filing targets: SENATE
U S ECOLOGY CORPORATION via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · 1T
Energy bill; NRC oversight; hazerdous waste issues; and Energy and Water Appropriations
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
THE SHAW GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · 1T
NRC regulations relating to the construction of nuclear power plants.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
NEXTERA ENERGY INC via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · 1T
NRC oversight; Clean Air Act.
Energy Bill, Section 45 wind energy tax credit extension, dividend rates.
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
UNITED STATES ENRICHMENT CORPORATION (USEC) via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · Q1
Funding Issues; Energy Bill; and Energy and Water Appropriations.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, White House Office
THE SHAW GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · Q1
NRC regulations relating to the construction of nuclear power plants.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
PINNACLE WEST CAPITAL CORPORATION via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · Q1
NRC Oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
NUCLEAR ENERGY INSTITUTE via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · Q1
Nuclear Regulatory Commission
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEXTERA ENERGY INC via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · Q1
NRC oversight; Clean Air Act.
Energy Bill, Section 45 wind energy tax credit extension, dividend rates.
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
U S ECOLOGY CORPORATION via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · Q1
Energy bill; NRC oversight; hazerdous waste issues; and Energy and Water Appropriations
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
CHENIERE ENERGY via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · Q1
Issues regarding LNG.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
TURNER ENTERPRISES, INC. via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · Q1
Legislation affecting solar and wind energy
Legislation affecting solar and wind energy
Filing targets: SENATE
COCA-COLA COMPANY via WILLIAMS AND JENSEN, PLLC
2014 · first_quarter · Q1
renewable energy issues
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
CHENIERE ENERGY via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
Issues regarding LNG.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
WINE AND SPIRITS WHOLESALERS OF AMERICA via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
Support state-based alcohol regulation systems. Issues relating to alcohol regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISA via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
Regulation of debit and credit card practices; interchange fees; prepaid card fee; and financial literacy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TE CONNECTIVITY, INC. via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
Federal contracting issues; international tax on foreign direct investment and general corporate tax issues.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Coast Guard (USCG), U.S. Trade Representative (USTR)
PFIZER via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
Drug safety and drug counterfeiting; Rebates for Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages; track and trace; H.R. 3204; S. 959.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURNER ENTERPRISES, INC. via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
Legislation affecting solar and wind energy
Legislation affecting solar and wind energy
Filing targets: SENATE
UNITED STATES ENRICHMENT CORPORATION (USEC) via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
Funding Issues; Energy Bill; and Energy and Water Appropriations.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, White House Office
THE SHAW GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
NRC regulations relating to the construction of nuclear power plants.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
PINNACLE WEST CAPITAL CORPORATION via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
NRC Oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
NUCLEAR ENERGY INSTITUTE via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
Nuclear Regulatory Commission
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEXTERA ENERGY INC via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
Energy Bill, Section 45 wind energy tax credit extension, dividend rates.
NRC oversight; Clean Air Act.
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
U S ECOLOGY CORPORATION via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
Energy bill; NRC oversight; hazerdous waste issues; and Energy and Water Appropriations
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
COCA-COLA COMPANY via WILLIAMS AND JENSEN, PLLC
2013 · fourth_quarter · Q4
renewable energy issues
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
VISA via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
Regulation of debit and credit card practices; interchange fees; prepaid card fee; and financial literacy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WINE AND SPIRITS WHOLESALERS OF AMERICA via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
Support state-based alcohol regulation systems. Issues relating to alcohol regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · 1A
Nuclear Regulatory Commission
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PINNACLE WEST CAPITAL CORPORATION via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
NRC Oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
UNITED STATES ENRICHMENT CORPORATION (USEC) via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
Funding Issues; Energy Bill; and Energy and Water Appropriations.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, White House Office
U S ECOLOGY CORPORATION via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · 3A
Energy bill; NRC oversight; hazerdous waste issues; and Energy and Water Appropriations
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
THE SHAW GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
NRC regulations relating to the construction of nuclear power plants.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
NUCLEAR ENERGY INSTITUTE via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
Nuclear Regulatory Commission
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEXTERA ENERGY INC via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
Energy Bill, Section 45 wind energy tax credit extension, dividend rates.
NRC oversight; Clean Air Act.
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
TE CONNECTIVITY, INC. via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
Federal contracting issues; international tax on foreign direct investment and general corporate tax issues; student loan legislation.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Coast Guard (USCG), U.S. Trade Representative (USTR)
PFIZER via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
Drug safety and drug counterfeiting; Rebates for Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages; track and trace; H.R. 3204; S. 959.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COCA-COLA COMPANY via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
renewable energy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURNER ENTERPRISES, INC. via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
Legislation affecting solar and wind energy
Legislation affecting solar and wind energy
CHENIERE ENERGY via WILLIAMS AND JENSEN, PLLC
2013 · third_quarter · Q3
Issues regarding LNG.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES ENRICHMENT CORPORATION (USEC) via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
Funding Issues; Energy Bill; and Energy and Water Appropriations.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, White House Office
THE SHAW GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
NRC regulations relating to the construction of nuclear power plants.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
PINNACLE WEST CAPITAL CORPORATION via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
NRC Oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
NUCLEAR ENERGY INSTITUTE via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
Nuclear Regulatory Commission
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHEAST UTILITIES via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · 2T
Transmission issues related to the utility sector.
NEXTERA ENERGY INC via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
NRC oversight; Clean Air Act.
Energy Bill, Section 45 wind energy tax credit extension, dividend rates.
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
U S ECOLOGY CORPORATION via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
Energy bill; NRC oversight; hazerdous waste issues; and Energy and Water Appropriations
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
COCA-COLA COMPANY via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
renewable energy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OWENS-ILLINOIS INC via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · 2A
Legislation re: recycling; environmental legislation impacting manufacturing sector, including EPA regulation.
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
OWENS-ILLINOIS INC via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
Legislation re: recycling; environmental legislation impacting manufacturing sector, including EPA regulation.
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
CHENIERE ENERGY via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
Issues regarding LNG.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
TURNER ENTERPRISES, INC. via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
Legislation affecting solar and wind energy
Legislation affecting solar and wind energy
WINE AND SPIRITS WHOLESALERS OF AMERICA via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
Support state-based alcohol regulation systems. Issues relating to alcohol regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISA via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
Regulation of debit and credit card practices; interchange fees; prepaid card fee; and financial literacy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TE CONNECTIVITY, INC. via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
Federal contracting issues; international tax on foreign direct investment and general corporate tax issues; student loan legislation.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Coast Guard (USCG), U.S. Trade Representative (USTR)
PFIZER via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · Q2
Drug safety and drug counterfeiting; Rebates for Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AK STEEL via WILLIAMS AND JENSEN, PLLC
2013 · second_quarter · RR
General energy, general tax and general trade issues.
General energy, general tax and general trade issues.
General energy, general tax and general trade issues.
WINE AND SPIRITS WHOLESALERS OF AMERICA via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Support state-based alcohol regulation systems. Issues relating to alcohol regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISA via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Regulation of debit and credit card practices; interchange fees; prepaid card fee; and financial literacy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TE CONNECTIVITY, INC. via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Federal contracting issues; international tax on foreign direct investment and general corporate tax issues.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Coast Guard (USCG), U.S. Trade Representative (USTR)
PFIZER via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Drug safety and drug counterfeiting; Rebates for Medicare Part D; animal health; Federal preemption for prescription drugs; drug importation; and drug shortages. H.R. 1513; S. 810
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COCA-COLA COMPANY via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
renewable energy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OWENS-ILLINOIS INC via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Legislation re: recycling; environmental legislation impacting manufacturing sector, including EPA regulation.
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
TURNER ENTERPRISES, INC. via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Legislation affecting solar and wind energy
Legislation affecting solar and wind energy
UNITED STATES ENRICHMENT CORPORATION (USEC) via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Funding Issues; Energy Bill; and Energy and Water Appropriations.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, White House Office
THE SHAW GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
NRC regulations relating to the construction of nuclear power plants.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
PUBLIC SERVICE COMPANY OF NEW HAMPSHIRE via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · 1T
transmission issues
transmission issues
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
PINNACLE WEST CAPITAL CORPORATION via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
NRC Oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
NUCLEAR ENERGY INSTITUTE via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Nuclear Regulatory Commission
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHEAST UTILITIES via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Transmission issues related to the utility sector.
NEXTERA ENERGY INC via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Energy Bill, Section 45 wind energy tax credit extension, dividend rates, H.R. 8.
NRC oversight; Clean Air Act.
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
U S ECOLOGY CORPORATION via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Energy bill; NRC oversight; hazerdous waste issues; and Energy and Water Appropriations
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
CHENIERE ENERGY via WILLIAMS AND JENSEN, PLLC
2013 · first_quarter · Q1
Issues regarding LNG.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
OWENS-ILLINOIS INC via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Legislation promoting better recycling data. Environmental legislation impacting the manufacturing sector, including EPA regulation moratorium amendments.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
WINE AND SPIRITS WHOLESALERS OF AMERICA via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Support state-based alchol regulation systems. Issues relating to alchol regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISA via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Regulation of debit and credit card practices; interchange fees; prepaid card fee; and financial literacy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TE CONNECTIVITY, INC. via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Federal contracting issues; international tax on foreign direct investment and general corporate tax issues.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Coast Guard (USCG), U.S. Trade Representative (USTR)
PFIZER via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Drug safety and drug counterfeiting; Rebates for Medicare Part D; animal health; Federal preemption for prescription drugs; drug importation; and drug shortages. H.R. 1513; S. 810
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COCA-COLA COMPANY via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
renewable energy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES ENRICHMENT CORPORATION (USEC) via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Funding Issues; Energy Bill; and Energy and Water Appropriations.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, White House Office
THE SHAW GROUP, INC. via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
NRC regulations relating to the construction of nuclear power plants.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
PUBLIC SERVICE COMPANY OF NEW HAMPSHIRE via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
transmission issues
transmission issues
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
PINNACLE WEST CAPITAL CORPORATION via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
NRC Oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
NUCLEAR ENERGY INSTITUTE via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Nuclear Regulatory Commission
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHEAST UTILITIES via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Transmission issues related to the utility sector.
NEXTERA ENERGY INC via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Energy Bill, Section 45 wind energy tax credit extension, dividend rates, H.R. 8.
NRC oversight; Clean Air Act.
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, State, Dept of (DOS)
U S ECOLOGY CORPORATION via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Energy bill; NRC oversight; hazerdous waste issues; and Energy and Water Appropriations
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
TURNER ENTERPRISES, INC. via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Legislation affecting solar and wind energy
Legislation affecting solar and wind energy
CHENIERE ENERGY via WILLIAMS AND JENSEN, PLLC
2012 · fourth_quarter · Q4
Issues regarding LNG.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
OWENS-ILLINOIS INC via WILLIAMS AND JENSEN, PLLC
2012 · third_quarter · Q3
Legislation promoting better recycling data. Environmental legislation impacting the manufacturing sector, including EPA regulation moratorium amendments.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
COCA-COLA COMPANY via WILLIAMS AND JENSEN, PLLC
2012 · third_quarter · Q3
renewable energy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHENIERE ENERGY via WILLIAMS AND JENSEN, PLLC
2012 · third_quarter · Q3
Issues regarding LNG.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
WINE AND SPIRITS WHOLESALERS OF AMERICA via WILLIAMS AND JENSEN, PLLC
2012 · third_quarter · Q3
Support state-based alchol regulation systems. Issues relating to alchol regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISA via WILLIAMS AND JENSEN, PLLC
2012 · third_quarter · Q3
Regulation of debit and credit card practices; interchange fees; prepaid card fee; and financial literacy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TE CONNECTIVITY, INC. via WILLIAMS AND JENSEN, PLLC
2012 · third_quarter · Q3
Federal contracting issues; international tax on foreign direct investment and general corporate tax issues.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
PFIZER via WILLIAMS AND JENSEN, PLLC
2012 · third_quarter · Q3
Drug safety and drug counterfeiting; Rebates for Medicare Part D; animal health; Federal preemption for prescription drugs; drug importation; and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURNER ENTERPRISES, INC. via WILLIAMS AND JENSEN, PLLC
2012 · third_quarter · Q3
Legislation affecting solar and wind energy
Legislation affecting solar and wind energy